about
P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction.Neuronal and glial purinergic receptors functions in neuron development and brain diseasePathophysiology of astroglial purinergic signallingBlockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissuePurinergic signaling induces thrombospondin-1 expression in astrocytesEnhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.Differential effects of P2Y1 deletion on glial activation and survival of photoreceptors and amacrine cells in the ischemic mouse retina.Opposing effects of P2X(7) and P2Y purine/pyrimidine-preferring receptors on proliferation of astrocytes induced by fibroblast growth factor-2: implications for CNS development, injury, and repairAdenosine: an activity-dependent axonal signal regulating MAP kinase and proliferation in developing Schwann cells.P2Y2 receptor expression is altered in rats after spinal cord injury.Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.Functions of optic nerve glia: axoglial signalling in physiology and pathology.2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.Extracellular ATP induces graded reactive response of astrocytes and strengthens their antioxidative defense in vitro.Roles of P2 receptors in glial cells: focus on astrocytesEnteric glia mediate neuron death in colitis through purinergic pathways that require connexin-43 and nitric oxide.Antagonism of purinergic signalling improves recovery from traumatic brain injuryMorphological and physiological interactions of NG2-glia with astrocytes and neurons.Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.Short- and long-term (trophic) purinergic signalling.Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathwaysATP signalling in epilepsy.P2Y2 nucleotide receptors inhibit trauma-induced death of astrocytic cells.P2 receptors are involved in the mediation of motivation-related behavior.Differential modulation of ATP-induced calcium signalling by A1 and A2 adenosine receptors in cultured cortical astrocytes.Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus.Modulation of astrocyte P2Y1 receptors by the carboxyl terminal domain of the gap junction protein Cx43.ATP evokes Ca2+ signals in cultured foetal human cortical astrocytes entirely through G protein-coupled P2Y receptors.P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.Purines regulate adult brain subventricular zone cell functions: contribution of reactive astrocytes.Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production.Effects of IP3R2 Receptor Deletion in the Ischemic Mouse Retina.Mechanical lesion activates newly identified NFATc1 in primary astrocytes: implication of ATP and purinergic receptors.Purinergic receptor signaling regulates N-cadherin expression in primary astrocyte cultures.Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors.ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice.
P2860
Q26749031-DB9DAD4D-AEDB-48A8-9F01-4FB973B5583AQ27500377-EF679182-CAA6-424C-BAD9-38205FA72AF6Q28384801-9734CB16-89A1-4E85-9D60-D399AE0BFDDAQ28391993-B665495C-E6F4-4D4F-B068-0BA3581CB2D2Q28573378-B33AC220-7294-4ADB-B3DA-EC369AE6A57CQ30902463-F80E1A51-9900-43A0-9BB8-99A5592D37D5Q34007859-5AE7646E-AE96-4AE2-81BD-93772BC67BBAQ34021603-ADC4AB22-4163-4F01-9CFE-F1317C3BE8A6Q34249267-4B9D4ED2-37AE-4F16-B7DB-BF942B7F13C9Q35576857-876A2F22-4463-43BB-A87A-3DB83384464DQ35600801-355517D9-789E-46B5-97F3-11AE6ED6F4B8Q35944026-97000AB2-7A97-43FF-B69A-49D2356F0CDBQ36128578-064F66E4-3530-4906-A1AC-AF79C020A30DQ36156190-29FFEE67-92D9-4386-AC69-3AC1D1F2FDA3Q36174059-875BC73A-39DF-49DB-8A39-470A1E40FBB1Q36450149-54E1230C-7AF0-4850-9F86-E44D26F58ADAQ36581119-9729FD99-6D23-481D-A084-12355BB41A9BQ36801709-9965FCF5-4762-432C-B29E-15375CFE0351Q37848660-8AE5076F-4EA0-479F-9EBB-4F14D0C62552Q38885851-049EA75F-E84F-4217-A42C-1D5B659A8849Q39955622-9EDB2C28-4B12-48B8-8C7A-47CE3459F3AAQ40079121-5E39C858-5D23-4E2C-9B7F-CE5CB0B94C58Q40080545-CB84C989-D3D3-44AB-8BF6-BF53B30E4AFDQ40723755-F3875744-5A22-4DD3-B5CF-130090C823CFQ41957449-C29A4104-66EF-410E-9113-1300D7EE8047Q42108936-F7E6EBD0-3AFE-479B-957F-91BCA770248DQ42159344-980E57FA-180F-4B6B-9041-7B4C971CD3B2Q42359690-175900B0-57F4-4FB0-9BE1-DDF94A0E6085Q43270590-3BA316A2-922C-456B-AE9B-F4587971E4E2Q44112249-96ADFBDB-9C6A-442B-91CB-320E0F335ED8Q44357511-06E060F5-225B-469C-B620-3C20E3E4ABB2Q45985232-984B8F54-5823-4A54-879C-D9445ADE784EQ46620286-4DF33BE6-4B2D-46F9-B09F-A830DAB56909Q46817699-BE96795D-6A97-4932-9BB3-5B4ECB326F7CQ47222038-3210BF82-BF2C-4E0A-8ABE-9D671167B6E9Q48827181-7E40B0EB-8575-4DE7-9A21-2AF416057D30
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
P2 receptor-types involved in astrogliosis in vivo
@ast
P2 receptor-types involved in astrogliosis in vivo
@en
P2 receptor-types involved in astrogliosis in vivo
@nl
type
label
P2 receptor-types involved in astrogliosis in vivo
@ast
P2 receptor-types involved in astrogliosis in vivo
@en
P2 receptor-types involved in astrogliosis in vivo
@nl
prefLabel
P2 receptor-types involved in astrogliosis in vivo
@ast
P2 receptor-types involved in astrogliosis in vivo
@en
P2 receptor-types involved in astrogliosis in vivo
@nl
P2093
P2860
P356
P1476
P2 receptor-types involved in astrogliosis in vivo
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0704353
P407
P577
2001-11-01T00:00:00Z